Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Mar 17, 2026

Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds
09:29

Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds

Published on: October 29, 2015

31.0K

3H-Penciclovir (3H-PCV) Uptake Assay.

Thillai V Sekar1, Ramasamy Paulmurugan1

  • 1Department of Radiology, Stanford University School of Medicine, Palo Alto, USA.

Bio-Protocol
|July 23, 2016
PubMed
Summary

This study details a protocol for measuring 3H-Penciclovir uptake in mammalian cells. This method quantifies the expression of Herpes simplex virus type 1 thymidine kinase (HSV1-TK), crucial for cancer gene therapy and PET imaging.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Addressing bioenergetic deficits and restoring mitochondrial health in transplanted islets using mesenchymal stem cells.

Stem cells translational medicine·2026
Same author

Scalable Synthesis of Calcium Fluoride Nanoparticles as a Novel Ultrasound Contrast Agent for Imaging Tumor Targeted Delivery of Therapeutics.

Chemical & biomedical imaging·2026
Same author

Exploring the Anticancer Potential of Pterostilbene Through Modulation of the NRF2-NFκB-COX-2 Network.

Journal of biochemical and molecular toxicology·2026
Same author

Enhancing Ultrasound Molecular Imaging: Toward Real-Time RPCA-Based Filtering to Differentiate Bound and Free Microbubbles.

IEEE transactions on ultrasonics·2026
Same author

NanoLuc-Driven Multiplex Imaging Platforms Incorporating Novel G-series Coelenterazine Variants.

Bioconjugate chemistry·2026
Same author

Improved Nondestructive Ultrasound Molecular Imaging With Lightweight Convolutional Neural Network.

IEEE transactions on medical imaging·2026

Area of Science:

  • Molecular Biology
  • Biotechnology
  • Cancer Research

Background:

  • Herpes simplex virus type 1 thymidine kinase (HSV1-TK) is a key enzyme in cancer gene therapy and reporter gene imaging.
  • HSV1-TK, along with its mutant HSV1-sr39TK, facilitates PET imaging using radiolabeled substrates.
  • Quantifying HSV1-TK expression is essential for evaluating therapeutic efficacy and imaging sensitivity.

Purpose of the Study:

  • To provide a detailed protocol for the 3H-Penciclovir (PCV) uptake assay in mammalian cells.
  • To establish a reliable method for determining HSV1-TK expression levels.
  • To support applications in cancer gene therapy and biological imaging.

Main Methods:

  • Utilizing radiolabeled 3H-Penciclovir (PCV) as a substrate for HSV1-TK.
  • Measuring the intracellular trapping of phosphorylated PCV, indicative of HSV1-TK activity.
  • Employing radioactive detection methods, such as scintillation counting, for quantification.

Main Results:

  • The protocol enables sensitive detection of PCV phosphorylation and subsequent trapping by HSV1-TK.
  • Quantifiable uptake of 3H-PCV correlates with HSV1-TK expression levels in cells and tissues.
  • The method provides a direct measure of functional HSV1-TK activity.

Conclusions:

  • The described 3H-Penciclovir uptake assay is a valuable tool for assessing HSV1-TK expression.
  • This protocol facilitates research in cancer gene therapy and in vivo imaging applications.
  • Accurate quantification of HSV1-TK is critical for advancing these therapeutic and diagnostic strategies.

More Related Videos

Use of Viral Entry Assays and Molecular Docking Analysis for the Identification of Antiviral Candidates against Coxsackievirus A16
06:03

Use of Viral Entry Assays and Molecular Docking Analysis for the Identification of Antiviral Candidates against Coxsackievirus A16

Published on: July 15, 2019

8.5K
Viral Nanoparticles for In vivo Tumor Imaging
14:04

Viral Nanoparticles for In vivo Tumor Imaging

Published on: November 16, 2012

17.8K

Related Experiment Videos

Last Updated: Mar 17, 2026

Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds
09:29

Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds

Published on: October 29, 2015

31.0K
Use of Viral Entry Assays and Molecular Docking Analysis for the Identification of Antiviral Candidates against Coxsackievirus A16
06:03

Use of Viral Entry Assays and Molecular Docking Analysis for the Identification of Antiviral Candidates against Coxsackievirus A16

Published on: July 15, 2019

8.5K
Viral Nanoparticles for In vivo Tumor Imaging
14:04

Viral Nanoparticles for In vivo Tumor Imaging

Published on: November 16, 2012

17.8K